PAR 2.38% 20.5¢ paradigm biopharmaceuticals limited..

Where we at?, page-450

  1. 591 Posts.
    lightbulb Created with Sketch. 64
    PAR for the course. I see what you did there. I have to agree, going on previous form, spend will likely be over.
    They need to get ahead of this with comms to shareholders.
    Lack of information is leading to catastrophising.
    I guess we will find out soon enough, but there needs to be a plan and a demonstrated way forward.
    No more 'oops I did it again'.
    Credibility is key here and they have some serious work to do.

    I don't doubt the science or the product for a moment, but they seem to be running out of runway and the captain needs to update the paying passengers with a plan.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.